Please join Dr. Vicki Basalyga, Pharm.D. BCPS, BCPPS, Director of the Section of Clinical Specialists and Scientists for today’s special edition podcast on COVID-19. Today we will be chatting with Dr. Ken Richman, Professor of Philosophy and Health Care Ethics and IRB Chair at MCPHS University in Boston about the ethics of research on COVID-19 during the 2020 pandemic.
Ken Richman is Professor of Philosophy and Healthcare Ethics at MCPHS University (formerly the Massachusetts College of Pharmacy and Health Sciences) in Boston. He has Chaired the MCPHS Institutional Review Board for more than 12 years. His published work explores the philosophy of medicine and bioethics, and other areas in philosophy. His current research addresses ethics and autism.
Vicki Basalyga, Pharm.D., BCPS, BCPPS, is the Director for the Section of Clinical Specialists and Scientists. In this role Vicki serves as an information resource and provides guidance to ASHP members regarding science and scientific developments affecting pharmacy practice in health systems. She serves as secretary to the Section executive committee and coordinates activities to accomplish the objectives established by the Section. Additionally, Vicki has assumed the position of Council Secretary for the ASHP's Council on Therapeutics.
Vicki received her Doctor of Pharmacy from Duquesne University and completed an ASHP accredited PGY1 at Children’s National Medical Center in Washington, DC. Vicki is also a Board Certified Pharmacotherapy Specialist and a Board Certified Pediatric Pharmacotherapy Specialist.
Prior to her current position at ASHP, Vicki practiced as critical care pharmacist in both the Cardiac Intensive Care Unit and the Pediatric Intensive Care Unit at Children’s National Medical Center in Washington, DC. Other activities Vicki performed included drafting policies and procedures, co-chairing the Antimicrobial Stewardship Program, creating and drafting order sets for CPOE conversion and precepting residents and students.